GB/T 44353.1-2024
ActiveMedical devices utilizing animal tissues and their derivatives—Part 1:Application of risk management
动物源医疗器械 第1部分：风险管理应用
Application Summary AI generated
This standard specifies the application of risk management principles to medical devices made from or incorporating animal tissues and their derivatives. It is used by manufacturers and regulatory bodies in the healthcare industry to identify and control hazards such as transmissible diseases, immunological reactions, and material degradation throughout the device lifecycle. The standard applies to the design, production, and post-market surveillance of products like biological heart valves, surgical sutures, and wound dressings derived from animal sources.
Related Standards
GB/T 19634-2005
In vitro diagnostic test systems-General technical requirements for blood-glucose monitoring systems for self-testing
GB/T 47486-2026
General technical requirements for vasculature-on-a-chip
GB/Z 30154-2013
Medical laboratories―Guidance on laboratory implementation of GB/T 22576-2008
GB/Z 16886.22-2022
Biological evaluation of medical devices—Part 22:Guidance on nanomaterials
GB/Z 43280-2023
Medical laboratories—Practical guidance for the estimation of measurement uncertainty
GB/Z 43281-2023
Guidance for supervisors and operators of point-of-care testing(POCT) devices
GB/Z 44363-2024
Pyrogenicity—Principles and methods for pyrogen testing of medical devices
GB/Z 157-2026
In vitro diagnostic test systems—Requirements and recommendations for detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by nucleic acid amplification methods
Transparency note: The application summary and key sentences on this page were automatically generated by AI from the standard's original text. This content has not been human-verified and should not be used for compliance or regulatory purposes. Always refer to the official standard document from the issuing authority.